Literature DB >> 1928942

Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs.

K Brudney1, J Dobkin.   

Abstract

The resurgence of tuberculosis in New York City has been largely attributed to the acquired immune deficiency syndrome (AIDS) epidemic. However, historical events predating the advent of AIDS and worsening economic and social conditions, including a rise in homelessness, have contributed significantly to the increase. We prospectively studied 224 consecutive patients with tuberculosis admitted to a large public hospital in New York over the first 9 months of 1988. Initial assessment included medical status, human immunodeficiency virus (HIV) risk factors, and detailed social information, including substance abuse history and housing status. All patients were tracked after discharge to determine compliance and cure rates. Tuberculosis patients were predominantly male (79%), with high rates of alcohol use (53%), intravenous drug and/or "crack" cocaine use (64%), and homelessness or unstable housing (68%). Half the patients had AIDS or AIDS-related complex (ARC) or were HIV antibody positive. A total of 178 patients were discharged on tuberculosis treatment, but 89% of these were lost to follow-up and failed to complete therapy. Of the 178 discharged patients, 48(27%) were readmitted within 12 months with confirmed active tuberculosis. Of these patients, 40 were discharged on treatment and at least 35 were again lost to follow-up. In a multivariate regression model noncompliance was significantly associated with the absence of AIDS or ARC (p less than 0.001), homelessness (p less than 0.005), and alcoholism (p less than 0.05). Because HIV infection and tuberculosis converge in a subpopulation with high rates of substance abuse and homelessness, the problem of ensuring treatment compliance may grow considerably in the future.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1928942     DOI: 10.1164/ajrccm/144.4.745

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  121 in total

1.  The DOTs strategy. More than just watching patients take their tablets.

Authors:  A Fanning
Journal:  West J Med       Date:  1999-07

2.  Tuberculosis in Seattle, 1949-1973: balancing public health and civil liberties.

Authors:  B H Lerner
Journal:  West J Med       Date:  1999-07

3.  HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic.

Authors:  D C Des Jarlais; M Marmor; P Friedmann; S Titus; E Aviles; S Deren; L Torian; D Glebatis; C Murrill; E Monterroso; S R Friedman
Journal:  Am J Public Health       Date:  2000-03       Impact factor: 9.308

4.  Does directly observed therapy work?

Authors:  W J Burman; W el-Sadr
Journal:  Am J Public Health       Date:  1999-04       Impact factor: 9.308

5.  Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997.

Authors:  C Des Jarlais; T Perlis; S R Friedman; T Chapman; J Kwok; R Rockwell; D Paone; J Milliken; E Monterroso
Journal:  Am J Public Health       Date:  2000-07       Impact factor: 9.308

6.  A statistical analysis of the seasonality in pulmonary tuberculosis.

Authors:  M Ríos; J M García; J A Sánchez; D Pérez
Journal:  Eur J Epidemiol       Date:  2000-05       Impact factor: 8.082

Review 7.  BCG and tuberculosis.

Authors:  M J Bannon
Journal:  Arch Dis Child       Date:  1999-01       Impact factor: 3.791

Review 8.  Optimizing tuberculosis control in the inner city.

Authors:  J M FitzGerald
Journal:  CMAJ       Date:  1999-03-23       Impact factor: 8.262

9.  Screening immigrants to Canada for tuberculosis: chest radiography or tuberculin skin testing?

Authors:  Dick Menzies
Journal:  CMAJ       Date:  2003-11-11       Impact factor: 8.262

10.  Screening and treatment of immigrants and refugees to Canada for tuberculosis: Implications of the experience of Canada and other industrialized countries.

Authors:  R E Thomas; B Gushulak
Journal:  Can J Infect Dis       Date:  1995-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.